| Primary |
| Parenteral Nutrition |
25.0% |
| Malabsorption |
22.8% |
| Drug Use For Unknown Indication |
10.9% |
| Product Used For Unknown Indication |
9.8% |
| Ovarian Cancer |
6.5% |
| Blood Glucose Decreased |
3.3% |
| Colon Cancer |
3.3% |
| Diabetes Prophylaxis |
3.3% |
| Endometrial Cancer |
2.2% |
| Hypoglycaemia |
2.2% |
| Anaemia |
1.1% |
| Blood Pressure |
1.1% |
| Deep Vein Thrombosis |
1.1% |
| Diabetes Mellitus |
1.1% |
| Fluid Replacement |
1.1% |
| Hyperkalaemia |
1.1% |
| Hyperthyroidism |
1.1% |
| Ileus |
1.1% |
| Postoperative Care |
1.1% |
| Prophylaxis |
1.1% |
|
| Anaphylactic Reaction |
13.3% |
| Wrong Technique In Drug Usage Process |
10.0% |
| Cardiac Arrest |
6.7% |
| Death |
6.7% |
| Incorrect Route Of Drug Administration |
6.7% |
| Infusion Site Pain |
6.7% |
| Medication Error |
6.7% |
| Ascites |
3.3% |
| Blood Glucose Increased |
3.3% |
| Chills |
3.3% |
| Device Malfunction |
3.3% |
| Emotional Distress |
3.3% |
| Extravasation |
3.3% |
| Hypernatraemia |
3.3% |
| Livedo Reticularis |
3.3% |
| Metabolic Acidosis |
3.3% |
| Overdose |
3.3% |
| Oxygen Saturation Decreased |
3.3% |
| Peritoneal Carcinoma |
3.3% |
| Peritoneal Dialysis Complication |
3.3% |
|
| Secondary |
| Product Used For Unknown Indication |
42.2% |
| Drug Use For Unknown Indication |
20.5% |
| Hypotension |
4.1% |
| Parenteral Nutrition |
3.7% |
| Irritability |
3.3% |
| Resuscitation |
3.3% |
| Overdose |
2.9% |
| Prophylaxis |
2.9% |
| Hypoglycaemia |
2.5% |
| Hypertension |
2.0% |
| Age-related Macular Degeneration |
1.6% |
| Pain |
1.6% |
| Chemotherapy |
1.2% |
| Dehydration |
1.2% |
| Diabetes Prophylaxis |
1.2% |
| Diabetic Ketoacidosis |
1.2% |
| Pyrexia |
1.2% |
| Spinal Anaesthesia |
1.2% |
| Systemic Lupus Erythematosus |
1.2% |
| Acute Lymphocytic Leukaemia |
0.8% |
|
| Vomiting |
13.2% |
| Hyponatraemia |
7.9% |
| Cerebral Haemorrhage |
5.3% |
| Hypoglycaemia |
5.3% |
| Infusion Related Reaction |
5.3% |
| Intra-uterine Death |
5.3% |
| Medication Error |
5.3% |
| Oxygen Saturation Decreased |
5.3% |
| Periorbital Haematoma |
5.3% |
| Peritonitis Bacterial |
5.3% |
| Renal Failure Acute |
5.3% |
| Respiratory Distress |
5.3% |
| Transient Ischaemic Attack |
5.3% |
| Tubulointerstitial Nephritis |
5.3% |
| Acidosis Hyperchloraemic |
2.6% |
| Anaphylactic Reaction |
2.6% |
| Brain Oedema |
2.6% |
| Crying |
2.6% |
| Heart Rate Increased |
2.6% |
| Hypersensitivity |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.4% |
| Drug Use For Unknown Indication |
26.1% |
| Prophylaxis |
6.1% |
| Hypertension |
3.2% |
| Pain |
2.4% |
| Constipation |
2.1% |
| Nausea |
2.1% |
| Acute Lymphocytic Leukaemia |
1.9% |
| Multiple Myeloma |
1.5% |
| Fluid Replacement |
1.5% |
| Hiv Infection |
1.3% |
| Hepatic Neoplasm Malignant |
1.2% |
| Diabetes Mellitus |
1.2% |
| Decreased Appetite |
1.1% |
| Premedication |
1.1% |
| Acute Myeloid Leukaemia |
1.0% |
| Diarrhoea |
1.0% |
| Abdominal Pain |
1.0% |
| Vomiting |
0.9% |
| Bacteraemia |
0.9% |
|
| Vomiting |
18.4% |
| Thrombocytopenia |
8.4% |
| Overdose |
6.7% |
| Sepsis |
6.5% |
| Death |
5.4% |
| Hyponatraemia |
5.2% |
| Septic Shock |
5.0% |
| Renal Failure Acute |
4.8% |
| Hypotension |
4.5% |
| Toxic Epidermal Necrolysis |
4.5% |
| Hypoglycaemia |
3.9% |
| Renal Failure |
3.7% |
| Electrolyte Imbalance |
3.2% |
| Tumour Lysis Syndrome |
3.2% |
| Unresponsive To Stimuli |
3.2% |
| Pneumonia |
2.8% |
| Renal Impairment |
2.8% |
| Respiratory Failure |
2.8% |
| Ovarian Cancer |
2.4% |
| Stomatitis |
2.4% |
|
